Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03457103 · ClinicalTrials.gov registry record · Phase 2
Capnometry-Assisted Breathing Training for COPD
A Phase 2 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 31
- Enrollment target
NCT03457103 is a Phase 2 study that has completed, run by NYU Langone Health. The registered enrollment target is 31 participants.
The verdict
NCT03457103, a Phase 2 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 31 participants
- Enrollment target
Study Summary
Capnometry-Assisted Breathing Training for COPD (CATCH) is a behavioral intervention that aims to promote optimal, self-regulated, mindful breathing. A portable capnometer is used in-session to provide continuous visual feedback of Respiratory Rate (RR), End-Tidal Carbon Dioxide Tension (ETCO2), and breathing pattern. The tailored CATCH intervention will emphasize a slow, quiet, regular, nasal breathing pattern, as well as pursed lips breathing (PLB). CATCH is once weekly for 6 weeks, for a total of 6 sessions; each session is approximately 60 minutes long. The principal investigator will implement the CATCH intervention. The principal investigator will implement the CATCH intervention. Patients will use the Address Stress app on a smart phone or computer tablet as part of their home breathing exercises.
Interventions
- DEVICE Capnometry-Assisted Training for COPD to Slow the Breath (CATCH)
- DEVICE Pulmonary Rehabilitation (PR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2015-06-16 |
| Est. Completion | 2019-08-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03457103
The ClinicalTrials.gov registry entry for NCT03457103 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Capnometry-Assisted Training for COPD to Slow the Breath (CATCH) is the first listed.
NCT03457103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03457103 about?
NCT03457103 is a clinical study titled "Capnometry-Assisted Breathing Training for COPD". Capnometry-Assisted Breathing Training for COPD (CATCH) is a behavioral intervention that aims to promote optimal, self-regulated, mindful breathing. A portable capnometer is used in-session to provide continuous visual feedback of Respiratory Rate (RR), End-Tidal Carbon Dioxide Tension (ETCO2), and...
What is the current status of trial NCT03457103?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 31 participants. The study started on 2015-06-16. Estimated completion is 2019-08-02.
What interventions are being tested in trial NCT03457103?
The interventions under investigation include: Capnometry-Assisted Training for COPD to Slow the Breath (CATCH) (DEVICE), Pulmonary Rehabilitation (PR) (DEVICE).
Who is sponsoring clinical trial NCT03457103?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.